Latest filing published 16 Feb 2021 for Recipharm AB, €32k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Carlos Santos von Bonhorst Silva: trading record in brief
All filings by Carlos Santos von Bonhorst Silva on record concern Recipharm AB. Over a trading history stretching from 27 April 2018 to 15 February 2021, the count stands at 2 filings.
The open-market side counts 1 purchase for €5,597 alongside 1 sale for €32k. Taken together, the sales exceed the purchases by €27k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2021 alone, the filings show no purchases and 1 sale.
Most recently, on 16 February 2021, the filings show an open-market sale worth €32k in Recipharm AB. The last insider purchase was made public on 30 April 2018, 3,114 days ago. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Carlos Santos von Bonhorst Silva
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,400 shares@ SEK 232.0085.2% of flowAktieISIN SE0005757267FI:csv-ae2653c5bc24b13af1bc
- 500 shares@ SEK 117.40100.0% of flowISIN SE0005757267FI:csv-1d2565f7f294510bfb47Canonical exit: 26 Jul 2018 (T+90)
2 of 2 declarations